| Biomarker ID | 1219 |
| PMID | 24086370 |
| Year | 2013 |
| Biomarker | Methylation Status of GSTP1 |
| Biomarker Basis | Methylation Based |
| Biomolecule | Methylation |
| Source | Serum |
| Subjects | Humans |
| Regulation | Hypermethylated in patients with Biochemical Recurrence |
| Odds Ratio/Hazard Ratio/Relative Risk | HR: [1.94 (95% CI:1.13,3.34)] |
| Effect on Pathways | Pathways include: Biological oxidations, Metapathway biotransformation, Pathways in cancer, T cell receptor regulation of apoptosis, Metabolism |
| Experiment | Biochemical recurrence Vs No Biochemical Recurrence |
| Type of Biomarker | Prognostic |
| Cohort | Meta- Analysis: 293 patients from three studies were chosen. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.02 |
| Method Used | Meta-analysis |
| Clinical | No |
| Remarks | Meta Analysis |
| Clinical Trial Number | NA |
| Degree Of Validity | NA |
| Technical Name | GSTP1 |